These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Contrast agents for MR imaging of the liver. Balci NC, Semelka RC. Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345 [Abstract] [Full Text] [Related]
6. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis. Wang L, Van den Bos IC, Hussain SM, Pattynama PM, Vogel MW, Krestin GP. Acta Radiol; 2008 Feb; 49(1):6-18. PubMed ID: 18210307 [Abstract] [Full Text] [Related]
7. [Secondary liver involvement in multiple myeloma: diagnostic imaging with magnetic resonance tomography (MRI)]. Ajaj W, Yang F, Ruehm SG. Rofo; 2003 May; 175(5):706-7. PubMed ID: 12743867 [No Abstract] [Full Text] [Related]
8. Diffusion and perfusion imaging of the liver. Chandarana H, Taouli B. Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054 [Abstract] [Full Text] [Related]
9. Contrast agents for magnetic resonance imaging of the liver. Josephson L, Groman E, Weissleder R. Targeted Diagn Ther; 1991 Dec; 4():163-87. PubMed ID: 1797156 [No Abstract] [Full Text] [Related]
10. Liver MR imaging: 1.5T versus 3T. Ramalho M, Altun E, Herédia V, Zapparoli M, Semelka R. Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):321-47, vi. PubMed ID: 17893053 [Abstract] [Full Text] [Related]
12. MR imaging of the liver. Martin DR, Danrad R, Hussain SM. Radiol Clin North Am; 2005 Sep; 43(5):861-86, viii. PubMed ID: 16098344 [Abstract] [Full Text] [Related]
13. Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. Marin D, Catalano C, Rossi M, Guerrisi A, Di Martino M, Berloco P, Passariello R. J Magn Reson Imaging; 2008 Sep; 28(3):755-8. PubMed ID: 18777536 [Abstract] [Full Text] [Related]